Bonvests Holdings Full Year 2024 Earnings: EPS: S$0.005 (vs S$0.018 in FY 2023)
Bonvests Holdings (SGX:B28) reported its Full Year 2024 results, revealing a revenue of S$225.0 million, a 3.4% increase from FY 2023. However, net income fell by 74% to S$1.87 million, with an EPS of S$0.005, down from S$0.018 in the previous year. The profit margin also decreased to 0.8% from 3.3%. Additionally, Bonvests Holdings shares have declined by 7.2% over the past week, and there are three warning signs regarding the company's risks.
Bonvests Holdings (SGX:B28) Full Year 2024 Results
Key Financial Results
- Revenue: S$225.0m (up 3.4% from FY 2023).
- Net income: S$1.87m (down 74% from FY 2023).
- Profit margin: 0.8% (down from 3.3% in FY 2023).
- EPS: S$0.005 (down from S$0.018 in FY 2023).
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Bonvests Holdings shares are down 7.2% from a week ago.
Risk Analysis
What about risks? Every company has them, and we've spotted 3 warning signs for Bonvests Holdings (of which 1 can't be ignored!) you should know about.
If you're looking to trade Bonvests Holdings, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored Content
